Our Mission: Revolutionizing Retinal Disease Treatment
Founded in 2024, Orsight Pharma was created to address one of the most urgent challenges in ophthalmology: preventing vision loss from neovascular Age-related Macular Degeneration (nAMD). By combining cutting-edge science with deep clinical insight, we are advancing therapy that goes beyond the limitations of current anti-VEGF treatments, targeting broader biological mechanisms.
Driven by a commitment to scientific excellence, patient-centered solutions, and long-term impact, Orsight Pharma is shaping a future where durable, effective vision preservation is accessible to millions worldwide.
A Future Without Preventable Blindness
At Orsight Pharma, we believe in a world where vision loss due to retinal diseases can be prevented through innovation, dedication, and collaboration. We are committed to scientific excellence, patient-centric solutions, and global accessibility.
Team Members
Our Board
Let's Shape the Future of Vision Care Together
Orsight Pharma is redefining the future of retinal disease treatment. If you are interested in learning more, collaborating, or investing in our breakthrough therapies, we invite you to get in touch.
